Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...
Tenaya’s Highly Selective HDAC6 Inhibitor TN-301 Outperformed Approved Pan-HDAC Inhibitor Givinostat in Improving Muscle Function and Correcting ...
New injection helps body produce heart protecting hormone for weeks after heart attack, improving recovery potential.